Over 3 Million Eye Drops Recalled Amid Sterility Concerns
via HealthDayMONDAY, April 6, 2026 — More than 3 million bottles of over-the-counter eye drops are being recalled after officials raised concerns about the product's safety.
The U.S. Food and Drug Administration (FDA) said the recall affects 3,111,072 bottles made by K.C. Pharmaceuticals of Pomona, California.
The agency said the recall was issued due to a "lack of assurance of sterility," NBC News reported.
The eye drops were sold under several names, including:
They were available at major retailers such as CVS, Walgreens and Rite Aid, the FDA said.
There have been no reports of injuries linked to the drops so far.
The FDA classified this as a Class II recall, which means the products could cause temporary or medically reversible health problems.
It’s not yet clear what caused the issue, either.
The recall includes several types of 0.5-ounce (15 mL) bottles, NBC News reported. Among them:
Sterile Eye Drops Soothing Tears (polyethylene glycol 400 0.4% and propylene glycol 0.3%), 0.5 OZ 0.5 fl oz (15 mL) bottles
A complete list of affected drops and where they were sold is available on the FDA website.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-07 01:53
Read more
- Drop in Daytime Activity Patterns Precedes Disability Worsening in MS
- Global Maternal Mortality Ratio Reported at 190.5 Deaths/100,000 Livebirths in 2023
- Wegovy Pill Demonstrated Greater Weight Loss Than Orforglipron and Lower Odds of Stopping Medication Due to Side Effects in a New Indirect Comparison to be Presented at Obesity Medicine Association 2026
- Early-Life Exposure to PFAS Linked to Bone Development in Adolescence
- Machine Learning Model Accurately Predicts Pregnant Women at Risk for Preeclampsia
- Lantheus Announces FDA Approval of Pylarify TruVu (piflufolastat F 18) Injection
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions